Selection of blockbuster announcements

Fuhong Hanlin (02696): phase 2 clinical study of HLX10 combined with HLX07 in the treatment of HNSCC completed the first patient administration in Chinese mainland.

CITIC (06030)'s first-half net profit increased by 38.47% to 8.926 billion yuan compared with the same period last year.

Wuxi Biologics (02269) expects medium-term shareholder profits to increase by more than 58% compared with the same period last year.

Financial Street property (01502) issued 13.5 million shares due to full exercise of the over-allotment option

Profit turning to loss IMAX CHINA (01970) medium-term loss of $35.248 million

Important matters

Fuhong Hanlin-B (02696): application for marketing authorization of trastuzumab HLX02 for injection approved by European Commission

Stone four Pharmaceutical Group (02005) plans to spin off the integration platform of API and medical materials to be listed in mainland China.

Yongsheng Life Service (01995) enters value-added telecom services through the establishment of VIE structure

Shandong Xinhua Pharmaceutical Co., Ltd. (00719): diphenhydramine Hydrochloride tablets (25mg) passed generic drug consistency evaluation

China CITIC Bank Corporation (00998) To set up a partnership to invest in construction machinery of Xugong Group

Fuhong Hanlin (02696): phase 2 clinical study of HLX10 combined with HLX07 in the treatment of HNSCC completed the first patient administration in Chinese mainland.

Listing of new shares

Financial Street property (01502) issued 13.5 million shares due to full exercise of the over-allotment option

Financial report data

CITIC (06030)'s first-half net profit increased by 38.47% to 8.926 billion yuan compared with the same period last year.

The total contract sales of Dayuecheng Real Estate (00207) in the first half of the year increased more than three times to 6.841 billion yuan compared with the same period last year.

Silver City Life Services (01922) expects the net profit attributable to owners to increase by not less than 60% in the first half of the year compared with the same period last year.

Wuxi Biologics (02269) expects medium-term shareholder profits to increase by more than 58% compared with the same period last year.

The net profit of Longxiang Group (00935) increased by more than 40% in the first half.

Xintian Green Energy (00956) accumulated power generation of 5.083 million MW hours in the first half of the year increased by 4.48% compared with the same period last year.

China Pengfei Group (03348) expects the medium-term net profit attributable to shareholders to increase to more than 48 million yuan.

Revenue decline year-on-year Heng Investment Securities (01476) expected profit attributable to shareholders in the medium term is about 134 million yuan

Turn losses into profits Jintai Energy Holdings (02728) expected medium-term net profit of HK $55 million

Shuangyun Holdings (01706) expects the comprehensive profit in the first half of the year to decrease by 85% compared with the same period last year.

Huazhong vehicle (06830) expects medium-term net profit to decrease by about 55% compared with the same period last year.

Baofeng Fashion (01121) first-half sales of 48.2 million yuan fell 51.7% compared with the same period last year.

Profit and loss PRADA S.p.A. (01913) the group made a net loss of about 180 million euros in the first half of the year

New Oriental Education & Technology Group online (01797) expects the annual net loss to increase significantly to 700-800 million yuan.

From profit to loss Guangdong Transportation (03399) expects a medium-term net loss of no more than 133 million yuan

Profit turning to loss IMAX CHINA (01970) medium-term loss of $35.248 million

From profit to loss Nature Home (02083) expects a loss of no more than 35 million yuan in the first half of the year

From profit to loss Huajin International Holdings (02738) expected loss attributable to shareholders in the medium term is about 16 million yuan

Or profit and loss Quanta Electric Group Holdings (01750) expected medium-term net loss of not less than HK $15 million

Repurchase cancellation

Huatai (06886) spent 15.2965 million yuan to buy back 734600 A shares on July 29th.

China Water (00855) spent HK $2.3938 million to buy back 384000 shares on July 29th

Fusen Pharmaceutical (01652) spent HK $2.1459 million to buy back 675000 shares on July 29th

DYNAM JAPAN (06889) spent HK $1.1652 million to buy back 208800 shares on July 29th

Additional placement

Wuxi Apptec (02359) proposes to place 68.2054 million shares to raise a net HK $7.29 billion